Loading…
PMV Pharmaceuticals, Inc. is projected to rise to $1.57 by 2027, a +31% move from its current price of $1.20. PMVP is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.17 | $1.20 | $1.23 | -0.01% |
| May 30 | $1.15 | $1.20 | $1.25 | -0.01% |
| May 31 | $1.14 | $1.20 | $1.26 | -0.02% |
| Jun 1 | $1.13 | $1.20 | $1.27 | -0.03% |
| Jun 2 | $1.13 | $1.20 | $1.28 | -0.03% |
| Jun 3 | $1.12 | $1.20 | $1.28 | -0.04% |
| Jun 4 | $1.11 | $1.20 | $1.29 | -0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.11 | $1.20 | $1.29 | -0.04% |
| Week 2 | $1.08 | $1.20 | $1.33 | -0.09% |
| Week 3 | $1.06 | $1.20 | $1.36 | -0.13% |
| Week 4 | $1.03 | $1.20 | $1.39 | -0.18% |
| Week 5 | $1.02 | $1.20 | $1.41 | -0.22% |
| Week 6 | $0.9994 | $1.20 | $1.43 | -0.27% |
| Week 7 | $0.9847 | $1.20 | $1.45 | -0.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
PMV Pharmaceuticals, Inc. is a healthcare company focused on precision oncology, developing small molecule therapies targeting p53 mutations. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases.
PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey. It was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013.
PMV Pharmaceuticals, Inc. trades at $1.26 per share and has a market cap of $67.2M, ranking 4452. The current price is $1.26 with a market cap of $67.2M and a rank of 4452.
Forecast highlights show a neutral footing in 2026 with an average price of $1.26 and a 0% ROI, followed by a bullish trajectory thereafter. The 2027 average is $1.67, 2028 is $1.74, 2029 is $1.90, and 2030 is $2.08, with 2040 at $3.83 and 2050 at $7.42 on average. Max prices rise to $14.00 by 2050, with a max trajectory reflected by a 488.7% ROI in 2050.
A major floor 15.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 23.3% above — a clean break opens room to run.
A major ceiling 50.0% above — clearing it would confirm fresh momentum.
Key PMVP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PMVP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.26 | Sell | $1.24 | Sell |
| MA 10 | $1.27 | Sell | $1.28 | Sell |
| MA 20 | $1.34 | Sell | $1.32 | Sell |
| MA 50 | $1.37 | Sell | $1.35 | Sell |
| MA 100 | $1.31 | Sell | $1.34 | Sell |
| MA 200 | $1.34 | Sell | $1.33 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.26 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -144.79 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -14.89 | Sell |
| Bollinger %B (20,2) | 0.01 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.26 | Sell |
| Awesome (5,34) | -0.11 | Sell |
| Ultimate (7,14,28) | 29.32 | Buy |
| Momentum (10) | -0.22 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 1.23 | Sell |
| ADX (14) | 13.83 | Neutral |
| ATR (14) | 0.03 | Info |
Near term shows a neutral technical picture. RSI14 is 40, signaling modest momentum. SMA50 is $1.38 and SMA200 is $1.34, with a defined support at $1.25 and resistance at $1.48. The 30-day range runs from $1.04 to $1.52, and annualized volatility is 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.02 | $1.20 | $1.55 | 0% | Neutral | |
| $1.24 | $1.57 | $2.10 | +31% | Bullish | |
| $1.27 | $1.64 | $2.28 | +37% | Bullish | |
| $1.34 | $1.78 | $2.54 | +48% | Bullish | |
| $1.43 | $1.94 | $2.84 | +62% | Bullish | |
| $1.33 | $1.84 | $2.75 | +53% | Bullish | |
| $1.38 | $1.94 | $2.96 | +62% | Bullish | |
| $1.52 | $2.17 | $3.37 | +81% | Bullish | |
| $1.75 | $2.54 | $4.01 | +112% | Bullish | |
| $1.98 | $2.92 | $4.67 | +143% | Bullish | |
| $2.24 | $3.54 | $6.02 | +195% | Bullish | |
| $3.81 | $6.77 | $12.62 | +464% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.02 | $1.20 | $1.41 | +0.00% |
| June 2026 | $1.05 | $1.23 | $1.48 | +2.43% |
| July 2026 | $1.01 | $1.19 | $1.46 | -2.94% |
| August 2026 | $0.9764 | $1.16 | $1.44 | -2.37% |
| September 2026 | $1.00 | $1.20 | $1.49 | +3.06% |
| October 2026 | $1.01 | $1.22 | $1.53 | +1.61% |
| November 2026 | $0.9883 | $1.20 | $1.51 | -1.86% |
| December 2026 | $1.00 | $1.22 | $1.55 | +1.86% |
Click any year to see its month-by-month PMVP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PMVP price prediction for 2026 points to an average of $1.20 (low $1.02, high $1.55) — a potential gain of 0% on today's $1.20. Price action looks broadly range-bound.
In 2027, PMVP is projected to trade between $1.24 and $2.10, averaging $1.57 — a potential gain of +31% from today's $1.20. That is up +31% on the projected 2026 average. Buyers look set to stay in control over this stretch.
PMV Pharmaceuticals, Inc.'s 2028 outlook centres on $1.64, within a $1.27 to $2.28 range. That is up +5% on the projected 2027 average. That marks a +37% change versus current levels. Momentum favours further upside here.
By 2029, PMVP could reach as high as $2.54, with a base case around $1.78 and support toward $1.34 — roughly +48% from $1.20. Buyers look set to stay in control over this stretch.
Expect PMVP to range from $1.43 to $2.84 through 2030. The $1.94 average target implies a +62% move from current prices. That is up +9% on the projected 2029 average. Momentum favours further upside here.
The PMVP price prediction for 2031 points to an average of $1.84 (low $1.33, high $2.75) — a potential gain of +53% on today's $1.20. Buyers look set to stay in control over this stretch.
In 2032, PMVP is projected to trade between $1.38 and $2.96, averaging $1.94 — a potential gain of +62% from today's $1.20. That is up +6% on the projected 2031 average. Momentum favours further upside here.
PMV Pharmaceuticals, Inc.'s 2033 outlook centres on $2.17, within a $1.52 to $3.37 range. That is up +12% on the projected 2032 average. That marks a +81% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, PMVP could reach as high as $4.01, with a base case around $2.54 and support toward $1.75 — roughly +112% from $1.20. Momentum favours further upside here.
Expect PMVP to range from $1.98 to $4.67 through 2035. The $2.92 average target implies a +143% move from current prices. That is up +15% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The PMVP price prediction for 2040 points to an average of $3.54 (low $2.24, high $6.02) — a potential gain of +195% on today's $1.20. Momentum favours further upside here.
In 2050, PMVP is projected to trade between $3.81 and $12.62, averaging $6.77 — a potential gain of +464% from today's $1.20. That is up +91% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PMVP today (≈ 833.333333 PMVP) could be worth
$5,644.94
+$4,644.94 (+464%) by 2050 · US Dollar
Based on the average projected PMVP price of $6.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PMVPwould be worth at today's price.
$1,000 invested in PMVP on May 27, 2025 (≈ 1,111.111141 PMVP) would be worth
$1,333.33
+$333.33 (+33.3%) today · 1.33× · US Dollar
Based on a PMVP entry price of $0.9 vs. today's $1.2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.31 | $916.03 | -8.4% |
| 1 month ago | $1.44 | $833.33 | -16.7% |
| 3 months ago | $1.37 | $875.91 | -12.4% |
| 6 months ago | $1.32 | $909.09 | -9.1% |
| 1 year ago | $0.9 | $1,333.33 | +33.3% |
| All time (5.0y) ago | $31.48 | $38.12 | -96.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PMVP forecast.
Our base-case forecast reaches $2.40 around 2034.
Implied market cap at $2.40: $128M
The multi-year forecast shifts from neutral in 2026 to a bullish stance from 2027 onward, with the average price climbing from $1.67 in 2027 to $2.08 in 2030 and $7.42 in 2050. The forecast shows a progression of ROIs from 32.6% in 2027 to 64.8% in 2030, 54.7% in 2031, 65.7% in 2032, 86.1% in 2033, 117.6% in 2034, 151.8% in 2035, 204.2% in 2040, and 488.7% in 2050. Min and max paths accompany these averages: 2030 min $1.52 and max $3.06; 2040 min $2.39 and max $6.59; 2050 min $4.09 and max $14.00.
These figures are estimates and not guarantees. Actual results will depend on market conditions and other factors beyond the numbers provided.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $2.08 with a min of $1.52 and a max of $3.06, and an estimated ROI of 64.8%, with a bullish sentiment.
The forecast indicates a bullish sentiment from 2027 onward, with the avg price rising to $2.08 by 2030 and further to $7.42 by 2050, and ROI up to 488.7% by 2050. These are estimates, not guarantees.
Yes. The 2050 forecast lists a max of $14.00, with an avg of $7.42 and an ROI of 488.7%, and sentiment is BULLISH.
Current price is $1.26 and market cap is $67.2M.
RSI14 is 40 with a NEUTRAL sentiment. SMA50 is $1.38 and SMA200 is $1.34, with support at $1.25 and resistance at $1.48. The 30-day range is $1.04-$1.52 and annualized volatility is 50%.
PMV Pharmaceuticals, Inc. Community Discussion
0Share your PMV Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.